the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Single annual international break can reduce injuries says Barcelona’s Xavi

A revamped calendar with a single international break could resolve the travel time and injury issues faced by many players, Barcelona manager Xavi Hernandez said on Friday.

Barcelona keeper Marc-Andre ter Stegen was injured last week training with Germany and Spain midfielder Gavi tore a ligament on international duty ahead of the club’s return from international break at Rayo Vallecano on Saturday.

A high load of matches between clubs and national teams has caused many injuries, Xavi told reporters.

“I think FIFA are already considering it… one of the solutions would be nine months in the club and two months in the national team and from there a month of vacation,“ he said.

“This way at least so many trips would be avoided. For example, (Uruguay defender) Ronald Araujo or (Brazil forward) Raphinha (had) trips of 13, 14 hours. They came back yesterday, they have not rested.

“And this is the way all the teams are, not (just) us,“ he added.

Xavi cited the crowded calendar as one factor behind 19-year-old Gavi’s injury.

“Many coaches have said the calendar is very demanding and in this sense I think that is the main reason of Gavi’s injury, other than misfortune … breaking your cruciate ligament is often just a matter of bad luck.”

Barcelona, placed third after 13 matches, have not won two league games in a row since September as they seek to close a four-point gap with leaders Girona. – Reuters

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings